Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07604571
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast CancerNovartis PharmaceuticalsNot Yet RecruitingPhase 1
NCT07604571Not Yet Recruiting
Phase 1
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/...Novartis Pharmaceuticals
NCT07603765
Minimally Invasive Hemodynamic Monitoring in Cardiac AblationIstanbul University - CerrahpasaRecruiting
NCT07603765Recruiting
—
Minimally Invasive Hemodynamic Monitoring in Cardiac AblationIstanbul University - Cer...
NCT07603895
Evaluation of the Efficacy of a Probiotic Product as an Adjuvant Treatment for Vulvovaginal CandidiasisBioithas SLRecruitingNot Applicable
NCT07603895Recruiting
Not Applicable
Evaluation of the Efficacy of a Probiotic Product as an Adjuvant Treatment for V...Bioithas SL
NCT07605338
To Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established Dental Plaque and Gingivitis.Colgate PalmoliveActive Not RecruitingPhase 3
NCT07605338Active Not Recruiting
Phase 3
To Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established...Colgate Palmolive
NCT07600853
Development and Validation of an E-learning Module on Systemic Anticancer Therapy and Its Effectiveness on the Knowledge Attitude and Practice of Nurses in Administering Systemic Anticancer Agents at a Specialized Cancer Centres in Oman.Sultan Qaboos Comprehensive Cancer CenterNot Yet RecruitingNot Applicable
NCT07600853Not Yet Recruiting
Not Applicable
Development and Validation of an E-learning Module on Systemic Anticancer Therap...Sultan Qaboos Comprehensi...
NCT07602530
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical PracticeAstellas Pharma Europe Ltd.Recruiting
NCT07602530Recruiting
—
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezoline...Astellas Pharma Europe Lt...
NCT07603232
Long-Term Health Outcomes in Children Born With Hirschsprung's Disease and Anorectal Malformations at the Colorectal Centre of Excellence in QuebecMcGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling By Invitation
NCT07603232Enrolling By Invitation
—
Long-Term Health Outcomes in Children Born With Hirschsprung's Disease and Anore...McGill University Health...
NCT07604272
Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in MalesNorthwestern UniversityNot Yet RecruitingPhase 1
NCT07604272Not Yet Recruiting
Phase 1
Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Ingui...Northwestern University
NCT07604415
Active Versus Passive Anal Sphincter Training in Patients With Fecal IncontinenceComenius UniversityRecruitingNot Applicable
NCT07604415Recruiting
Not Applicable
Active Versus Passive Anal Sphincter Training in Patients With Fecal Incontinenc...Comenius University
NCT07602010
Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer StagingOslo University HospitalRecruiting
NCT07602010Recruiting
—
Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer StagingOslo University Hospital
NCT07604883
Early Molecular Biomarkers for Differentiating Parkinsonian SyndromesInternational Institute of Molecular and Cell Biology in WarsawNot Yet Recruiting
NCT07604883Not Yet Recruiting
—
Early Molecular Biomarkers for Differentiating Parkinsonian SyndromesInternational Institute o...
NCT07601997
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reperfusion Injury (REFINE Study)Myomed Technology (Shaoxing) Co., Ltd.Not Yet RecruitingNot Applicable
NCT07601997Not Yet Recruiting
Not Applicable
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reper...Myomed Technology (Shaoxi...
NCT07603050
A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in Patients With Type III Gaucher's DiseaseShanghai Vitalgen BioPharma Co., Ltd.Not Yet RecruitingPhase 1
NCT07603050Not Yet Recruiting
Phase 1
A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in P...Shanghai Vitalgen BioPhar...
NCT07602608
Platelet-Rich Plasma With or Without Tadalafil for Erectile DysfunctionBenha UniversityCompletedPhase 4
NCT07602608Completed
Phase 4
Platelet-Rich Plasma With or Without Tadalafil for Erectile DysfunctionBenha University
NCT07603843
Use of Cognitive Aid Methods in the Management of Status EpilepticusAnkara UniversityNot Yet RecruitingNot Applicable
NCT07603843Not Yet Recruiting
Not Applicable
Use of Cognitive Aid Methods in the Management of Status EpilepticusAnkara University
NCT07604025
Senna vs. Polyethylene Glycol 3350 for the Treatment of Retentive Encopresis in Children: a Randomized, Double-blinded, StudyAssaf-Harofeh Medical CenterNot Yet RecruitingEarly Phase 1
NCT07604025Not Yet Recruiting
Early Phase 1
Senna vs. Polyethylene Glycol 3350 for the Treatment of Retentive Encopresis in...Assaf-Harofeh Medical Cen...
NCT07601815
MEST : A School- Based Health Literacy Intervention TrialNorwegian Institute of Public HealthNot Yet RecruitingNot Applicable
NCT07601815Not Yet Recruiting
Not Applicable
MEST : A School- Based Health Literacy Intervention TrialNorwegian Institute of Pu...
NCT07604454
Muscle Energy Technique Combined With Mulligan Technique in Tennis ElbowUniversity of LahoreCompletedNot Applicable
NCT07604454Completed
Not Applicable
Muscle Energy Technique Combined With Mulligan Technique in Tennis ElbowUniversity of Lahore
NCT07604610
Epicardial Fat Tissue and Cardiometabolic Risk in Russian and Asian PopulationsNational Medical Research Center for Therapy and Preventive MedicineRecruiting
NCT07604610Recruiting
—
Epicardial Fat Tissue and Cardiometabolic Risk in Russian and Asian PopulationsNational Medical Research...
Result Breakdown
Not yet recruiting10 (50%)
Recruiting6 (30%)
Completed2 (10%)
Active, not recruiting1 (5%)
Enrolling by invitation1 (5%)
not_applicable8 (40%)
Not Specified6 (30%)
Phase 13 (15%)
Phase 31 (5%)
Phase 41 (5%)
Early Phase 11 (5%)